Opposing the SAFE Banking Act.
Advocating for a prohibition on hemp-derived intoxicants and advocating for restrictions on prediction markets.
Advocating against CCP-operating marijuana farms.
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)